You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for New Drug Application (NDA): 209512


✉ Email this page to a colleague

« Back to Dashboard


NDA 209512 describes NORVIR, which is a drug marketed by Abbott and Abbvie and is included in five NDAs. It is available from one supplier. Additional details are available on the NORVIR profile page.

The generic ingredient in NORVIR is ritonavir. There are twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ritonavir profile page.
Summary for 209512
Tradename:NORVIR
Applicant:Abbvie
Ingredient:ritonavir
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 209512
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORVIR ritonavir POWDER;ORAL 209512 NDA AbbVie Inc. 0074-3399 0074-3399-30 30 PACKET in 1 CARTON (0074-3399-30) / 1 POWDER in 1 PACKET

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrength100MG/PACKET
Approval Date:Jun 7, 2017TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.